Skip to main content
. 2019 Jun 26;11(7):896. doi: 10.3390/cancers11070896

Figure 4.

Figure 4

(A) Overall survival (OS) and (B) Chronic Lymphocytic Leukemia (CLL)-specific survival in +12 CLL patients with normal Lactate DeHydrogenase (LDH) levels vs. Fluorescence In Situ Hybridization (FISH) negative CLL patients.